ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.

导出 OA

翻译打印收藏纠错

第一作者： Dandan,Yu

第一单位： Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China.

作者： Dandan,Yu ^[1] ; Yali,Zhong ^[1] ; Xiaoran,Li ^[2] ; Yaqing,Li ^[1] ; Xiaoli,Li ^[1] ; Jing,Cao ^[1] ; Huijie,Fan ^[3] ; Yuan,Yuan ^[1] ; Zhenyu,Ji ^[4] ; Baoping,Qiao ^[5] ; Jian-Guo,Wen ^[6] ; Mingzhi,Zhang ^[6] ; Gunnar,Kvalheim ^[1] ; Jahn M,Nesland ^[7] ; Zhenhe,Suo ^[2]

作者单位： Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China. ^[1] Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. ^[2] Departments of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. ^[3] Department of Pathology, Capital Medical University, Beijing, China. ^[4] Department of Oncology, Henan Academy of Medical & Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China. ^[5] Department of Urodynamic Center and Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China. ^[6] Department of Cell Therapy, Cancer Institute, Radium Hospital, Oslo University Hospital, Oslo, Norway. ^[7]

关键词 CD44 and ABCG2 cancer stem cells chemotherapy cytokines interleukin